acetyl l carnitine vs tartrate X2 acetyl l carnitine vs l
Description
Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Results Descriptive statistics Descriptive statistics (means, standard deviations and a correlation matrix) are reported in Table 1
There were 59 DEPs identified in APP-treated serum in comparison with control group
83 XuJ.TianY
doi: 10.1016/j.clnu.2022.03.025 52
